Literature DB >> 2122644

Inhibition of ATP synthesis by 1-methyl-4-phenylpyridinium ion (MPP+) in mouse brain in vitro and in vivo.

Y Mizuno1, K Suzuki, N Sone.   

Abstract

The effects of the MPP+ ion on ATP synthesis were studied using mouse brains in vitro and in vivo. Oxidation of glutamate + malate in mitochondria estimated by polarography was significantly inhibited by MPP+, and synthesis of ATP was inhibited to approximately one-third of that of control by 0.05 mM of MPP+. Oxidation of alpha-glycerophosphate and succinate was not inhibited, and ATP was synthesized normally. In cerebral mitochondria of mice treated with 40 mg/kg of MPTP, oxidation of glutamate, pyruvate, and malate was also significantly inhibited, but ATP was synthesized in normal amounts. This inhibition was prevented by pretreatment of mice with pargyline. Our observation would give further support for the mitochondria hypothesis of the mechanism of neuronal degeneration in MPTP-induced parkinsonism.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2122644

Source DB:  PubMed          Journal:  Adv Neurol        ISSN: 0091-3952


  5 in total

1.  Inhibition of the Fe(III)-catalyzed dopamine oxidation by ATP and its relevance to oxidative stress in Parkinson's disease.

Authors:  Dianlu Jiang; Shuyun Shi; Lin Zhang; Lin Liu; Bingrong Ding; Bingqing Zhao; Gargey Yagnik; Feimeng Zhou
Journal:  ACS Chem Neurosci       Date:  2013-07-17       Impact factor: 4.418

2.  Thioredoxin-1 Rescues MPP+/MPTP-Induced Ferroptosis by Increasing Glutathione Peroxidase 4.

Authors:  Liping Bai; Fang Yan; Ruhua Deng; Rou Gu; Xianwen Zhang; Jie Bai
Journal:  Mol Neurobiol       Date:  2021-02-26       Impact factor: 5.590

Review 3.  Neonatal 6-hydroxydopamine lesioning of rats and dopaminergic neurotoxicity: proposed animal model of Parkinson's disease.

Authors:  Richard M Kostrzewa
Journal:  J Neural Transm (Vienna)       Date:  2022-03-12       Impact factor: 3.850

Review 4.  Current Progress of Mitochondrial Quality Control Pathways Underlying the Pathogenesis of Parkinson's Disease.

Authors:  Xue Jiang; Tao Jin; Haining Zhang; Jing Miao; Xiuzhen Zhao; Yana Su; Ying Zhang
Journal:  Oxid Med Cell Longev       Date:  2019-08-14       Impact factor: 6.543

Review 5.  Mitochondrial dysfunction in Parkinson's disease.

Authors:  Qingsong Hu; Guanghui Wang
Journal:  Transl Neurodegener       Date:  2016-07-22       Impact factor: 8.014

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.